Correlation Between Quantum BioPharma and Lantheus Holdings

Can any of the company-specific risk be diversified away by investing in both Quantum BioPharma and Lantheus Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantum BioPharma and Lantheus Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quantum BioPharma and Lantheus Holdings, you can compare the effects of market volatilities on Quantum BioPharma and Lantheus Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantum BioPharma with a short position of Lantheus Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantum BioPharma and Lantheus Holdings.

Diversification Opportunities for Quantum BioPharma and Lantheus Holdings

0.37

Correlation Coefficient

Quantum BioPharma  Lantheus Holdings

Weak diversification

The 3 months correlation between Quantum and Lantheus is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Quantum BioPharma and Lantheus Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantheus Holdings and Quantum BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantum BioPharma are associated (or correlated) with Lantheus Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantheus Holdings has no effect on the direction of Quantum BioPharma i.e., Quantum BioPharma and Lantheus Holdings go up and down completely randomly.

Pair Corralation between Quantum BioPharma and Lantheus Holdings

Given the investment horizon of 90 days Quantum BioPharma is expected to generate 3.22 times less return on investment than Lantheus Holdings. In addition to that, Quantum BioPharma is 4.23 times more volatile than Lantheus Holdings. It trades about 0.01 of its total potential returns per unit of risk. Lantheus Holdings is currently generating about 0.08 per unit of volatility. If you would invest  8,884  in Lantheus Holdings on October 5, 2024 and sell it today you would earn a total of  237.00  from holding Lantheus Holdings or generate 2.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Quantum BioPharma  vs.  Lantheus Holdings

Quantum BioPharma

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Quantum BioPharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Quantum BioPharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Lantheus Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lantheus Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pair Trading with Quantum BioPharma and Lantheus Holdings

The main advantage of trading using opposite Quantum BioPharma and Lantheus Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantum BioPharma position performs unexpectedly, Lantheus Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantheus Holdings will offset losses from the drop in Lantheus Holdings' long position.

The idea behind Quantum BioPharma and Lantheus Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.